based on individual patient factors over no treatment (PICO 5. In this solid organ transplant population, we conditionally recommend against using ROM due to potential harms in this population (PICO 5.9, 5.21, 5.16). This group of patients is typically considered at increased risk of fracture regardless of BMD, due to the known risk of OP associated with solid organ transplantation and anti-rejection medications. The overall certainty of evidence for treatment in this population is low, and